Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers (2020)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; OLIVEIRA, RENÊ DONIZETI RIBEIRO DE - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; CESTARI, ROBERTA NATÁLIA - FCFRP ; NARDOTTO, GLAUCO HENRIQUE BALTHAZAR - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1016/j.jpba.2020.113128
- Subjects: ESTATINAS; FARMACOCINÉTICA; FARMACOLOGIA; CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO; COMPOSTOS ORGÂNICOS; ESPECTROMETRIA DE MASSAS
- Keywords: Fluvastatin; Atorvastatin; Mevalonic acid; Mevalonolactone; Pharmacodynamics; Biomarker
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Pharmaceutical and Biomedical Analysis
- ISSN: 0731-7085
- Volume/Número/Paginação/Ano: v. 182, art. 113128, p. 1-7, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CESTARI, Roberta Natália et al. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, v. 182, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113128. Acesso em: 04 jun. 2024. -
APA
Cestari, R. N., Caris, J. A., Rocha, A., Nardotto, G. H. B., Oliveira, R. D. R. de, & Lanchote, V. L. (2020). Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 182, 1-7. doi:10.1016/j.jpba.2020.113128 -
NLM
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.jpba.2020.113128 -
Vancouver
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.jpba.2020.113128 - UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers
- Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin
- No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients
- Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose
- Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
- Detection of allopurinol and oxypurinol in canine urine by HPLC/MS-MS: focus on veterinary clinical pharmacokinetics
- Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia
- P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV
- Disposição cinética e transferência placentária do lopinavir e ritonavir em gestantes portadoras do HIV
Informações sobre o DOI: 10.1016/j.jpba.2020.113128 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003031356.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
